Hypotension News and Research

RSS
FDA approves Defitelio to treat hepatic veno-occlusive disease in adults, children

FDA approves Defitelio to treat hepatic veno-occlusive disease in adults, children

Romosozumab for postmenopausal women with osteoporosis meets co-primary endpoints in Phase 3 study

Romosozumab for postmenopausal women with osteoporosis meets co-primary endpoints in Phase 3 study

Promising phase II results for ozanimod in MS

Promising phase II results for ozanimod in MS

Basaglar (insulin glargine injection) approved to improve glycemic control in diabetes patients

Basaglar (insulin glargine injection) approved to improve glycemic control in diabetes patients

Bridion injection approved to reverse effects of neuromuscular blocking drugs used during certain types of surgery

Bridion injection approved to reverse effects of neuromuscular blocking drugs used during certain types of surgery

Lilly, Merck announce another immuno-oncology collaboration

Lilly, Merck announce another immuno-oncology collaboration

Mylan releases Clozapine Orally Disintegrating Tablets in U.S.

Mylan releases Clozapine Orally Disintegrating Tablets in U.S.

Lilly, Merck expand oncology clinical trial collaboration

Lilly, Merck expand oncology clinical trial collaboration

Lowering blood pressure below currently recommended targets reduces risk of stroke, heart attack

Lowering blood pressure below currently recommended targets reduces risk of stroke, heart attack

Intensive management of high blood pressure reduces rates of cardiovascular disease, lowers risk of death

Intensive management of high blood pressure reduces rates of cardiovascular disease, lowers risk of death

Early identification of physiological deterioration, appropriate care can improve outcomes in sepsis patients

Early identification of physiological deterioration, appropriate care can improve outcomes in sepsis patients

Sprout announces U.S. availability of Addyi for HSDD treatment in premenopausal women

Sprout announces U.S. availability of Addyi for HSDD treatment in premenopausal women

Boehringer Ingelheim announces FDA approval of Praxbind (idarucizumab)

Boehringer Ingelheim announces FDA approval of Praxbind (idarucizumab)

BDSI announces FDA approval of BUNAVAIL sNDA for manufacturing specification change

BDSI announces FDA approval of BUNAVAIL sNDA for manufacturing specification change

Tresiba and Ryzodeg approved to improve blood sugar control in adults with diabetes mellitus

Tresiba and Ryzodeg approved to improve blood sugar control in adults with diabetes mellitus

FDA grants 12-year exclusivity to RUCONEST (C1 esterase inhibitor [recombinant])

FDA grants 12-year exclusivity to RUCONEST (C1 esterase inhibitor [recombinant])

Amgen gets positive CHMP opinions for Kyprolis (carfilzomib) and BLINCYTO (blinatumomab)

Amgen gets positive CHMP opinions for Kyprolis (carfilzomib) and BLINCYTO (blinatumomab)

Feeling dizzy after standing up may signal serious conditions, increased risk of death

Feeling dizzy after standing up may signal serious conditions, increased risk of death

Higher doses of hydrocortisone not linked to neurodevelopmental impairments in low birth weight infants

Higher doses of hydrocortisone not linked to neurodevelopmental impairments in low birth weight infants

Amgen, Xencor partner to develop and commercialize new therapeutics for cancer immunotherapy, inflammation

Amgen, Xencor partner to develop and commercialize new therapeutics for cancer immunotherapy, inflammation